Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

A few thousand runners and walkers are expected to turn out April 5 at Norwin High School for the 17th annual Race for Grace, ...

International Childhood Cancer Day aims to spread awareness about childhood cancers. Childhood cancers (0-14 years of age) ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

DISCLAIMER “This segment is not intended to provide medical advice or be a substitute for professional medical guidance from ...

The following is a summary of "Periventricular gliomas. Evaluation of the risks associated with ventricular opening in two ...

JACKSON, Tenn. — Breakthrough treatment is available for those living with one form of brain cancer. FDA approval marks the ...

A 6-year-old boy died after he was diagnosed with glioma, a deadly brain tumour that doubled his weight in a short span.

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

This study presents a new prognostic model using mitophagy-related genes (MRGs) in glioma, a type of brain tumor, developed through bioinformatics. The model seeks to improve the understanding of ...